Truist Securities Maintains Hold on Nevro, Lowers Price Target to $10
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Richard Newitter maintains a Hold rating on Nevro (NYSE:NVRO) and lowers the price target from $11 to $10.
July 16, 2024 | 1:53 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Truist Securities has maintained its Hold rating on Nevro and lowered the price target from $11 to $10, indicating a cautious outlook.
The lowered price target from $11 to $10 by Truist Securities suggests a less optimistic view on Nevro's short-term performance, likely leading to a negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100